David Happel
President & CEO at Sagimet Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Sagimet Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sagimet Biosciences Inc. June 12, 202697.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 20, 2026 | Sagimet Biosciences Inc. | Open-market sale | −64,051 | $7.76 | $497,036 |
| Feb 19, 2026 | Sagimet Biosciences Inc. | Grant or award | +128,000 | — | — |
| Feb 10, 2026 | Sagimet Biosciences Inc. | Open-market sale | −12,101 | $5.36 | $64,861 |
| Jul 21, 2025 | Sagimet Biosciences Inc. | Open-market sale | −65,478 | $9.13 | $597,814 |
| Feb 6, 2025 | Sagimet Biosciences Inc. | Grant or award | +116,000 | — | — |
| Mar 26, 2024 | Sagimet Biosciences Inc. | Open-market purchase | +12,100 | $5.27 | $63,767 |
| Dec 7, 2023 | Sagimet Biosciences Inc. | Open-market purchase | +1,600 | $4.10 | $6,560 |
| Nov 17, 2023 | Sagimet Biosciences Inc. | Grant or award | +624,910 | — | — |
| Nov 16, 2023 | Sagimet Biosciences Inc. | Open-market purchase | +590 | $2.35 | $1,387 |
Questions about David Happel
What boards is David Happel on?
David Happel sits on the board of Sagimet Biosciences Inc.
What company is David Happel the CEO of?
David Happel has been President & CEO of Sagimet Biosciences Inc. since July 2023.
How long has David Happel served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.